CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 177 of 1
Non-Antibody Products
Page 177 of 1,297
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| 5-bromo-4-chloro-3-indolyl-β-D-Glucuronide (cyclohexylammonium salt hydrate) | A chromogenic substrate for β-glucuronidase; upon cleavage by β-… | 50 mg | 33591-50 | More Info |
| 5-bromo-2-chloro-4-Methoxypyrimidine | A building block used in the chemical synthesis of halogenated heterocycles | 10 g | 21862-10 | More Info |
| 5-bromo-2-chloro-4-Methoxypyrimidine | A building block used in the chemical synthesis of halogenated heterocycles | 25 g | 21862-25 | More Info |
| 5-bromo-2-chloro-4-Methoxypyrimidine | A building block used in the chemical synthesis of halogenated heterocycles | 5 g | 21862-5 | More Info |
| Bromocriptine-13C-d3 | An internal standard for the quantification of bromocriptine by GC- or LC-… | 1 mg | 26669-1 | More Info |
| Bromocriptine-13C-d3 | An internal standard for the quantification of bromocriptine by GC- or LC-… | 500 µg | 26669-500 | More Info |
| Bromocriptine (mesylate) | A dopamine receptor agonist (Kis = 1,659, 12.2, 12.2, 59.7, and 1,691 nM f… | 100 mg | 14598-100 | More Info |
| Bromocriptine (mesylate) | A dopamine receptor agonist (Kis = 1,659, 12.2, 12.2, 59.7, and 1,691 nM f… | 250 mg | 14598-250 | More Info |
| Bromocriptine (mesylate) | A dopamine receptor agonist (Kis = 1,659, 12.2, 12.2, 59.7, and 1,691 nM f… | 50 mg | 14598-50 | More Info |
| Bromocriptine (mesylate) | A dopamine receptor agonist (Kis = 1,659, 12.2, 12.2, 59.7, and 1,691 nM f… | 500 mg | 14598-500 | More Info |
| 8-bromo Cyclic ADP-Ribose (sodium salt) | A stable, cell-permeable analog that blocks calcium release evoked by cADP… | 1 mg | 18442-1 | More Info |
| 8-bromo Cyclic AMP | A PKA activator (Ka = 0.05 µM); selective for PKA over PKG (Ka = 5.8… | 10 mg | 18141-10 | More Info |
| 8-bromo Cyclic AMP | A PKA activator (Ka = 0.05 µM); selective for PKA over PKG (Ka = 5.8… | 100 mg | 18141-100 | More Info |
| 8-bromo Cyclic AMP | A PKA activator (Ka = 0.05 µM); selective for PKA over PKG (Ka = 5.8… | 25 mg | 18141-25 | More Info |
| 8-bromo Cyclic AMP | A PKA activator (Ka = 0.05 µM); selective for PKA over PKG (Ka = 5.8… | 50 mg | 18141-50 | More Info |
| 8-bromo Cyclic AMP (sodium salt) | A PKA activator (Ka = 0.05 µM); selective for PKA over PKG (Ka = 5.8… | 10 mg | 14431-10 | More Info |
| 8-bromo Cyclic AMP (sodium salt) | A PKA activator (Ka = 0.05 µM); selective for PKA over PKG (Ka = 5.8… | 25 mg | 14431-25 | More Info |
| 8-bromo Cyclic AMP (sodium salt) | A PKA activator (Ka = 0.05 µM); selective for PKA over PKG (Ka = 5.8… | 5 mg | 14431-5 | More Info |
| 8-bromo Cyclic GMP (sodium salt) | A cell-permeable analog of cGMP that preferentially activates cGMP-depende… | 10 mg | 15992-10 | More Info |
| 8-bromo Cyclic GMP (sodium salt) | A cell-permeable analog of cGMP that preferentially activates cGMP-depende… | 25 mg | 15992-25 | More Info |
| 8-bromo Cyclic GMP (sodium salt) | A cell-permeable analog of cGMP that preferentially activates cGMP-depende… | 5 mg | 15992-5 | More Info |
| 8-bromo Cyclic GMP (sodium salt) | A cell-permeable analog of cGMP that preferentially activates cGMP-depende… | 50 mg | 15992-50 | More Info |
| 8-Bromo-2'-deoxyadenosine-5'-O-triphosphate (sodium salt) | A dATP derivative; has been used to determine the substrate specificity of… | 2.9 mg | 38661-29 | More Info |
| 5-Bromo-2'-deoxycytidine | A derivative of 2'-deoxycytidine; induces DNA cross-linking and the format… | 1 g | 40644-1 | More Info |
| 5-Bromo-2'-deoxycytidine | A derivative of 2'-deoxycytidine; induces DNA cross-linking and the format… | 500 mg | 40644-500 | More Info |
| 8-Bromo-2'-deoxyguanosine-5'-O-triphosphate (sodium salt) | A dGTP derivative; has been used to determine the substrate specificity of… | 2.9 mg | 38549-29 | More Info |
| 5-Bromo-2'-deoxyuridine | A thymidine nucleoside derivative commonly used to identify proliferating… | 1 g | 15580-1 | More Info |
| 5-Bromo-2'-deoxyuridine | A thymidine nucleoside derivative commonly used to identify proliferating… | 250 mg | 15580-250 | More Info |
| 5-Bromo-2'-deoxyuridine | A thymidine nucleoside derivative commonly used to identify proliferating… | 50 mg | 15580-50 | More Info |
| 5-Bromo-2'-deoxyuridine | A thymidine nucleoside derivative commonly used to identify proliferating… | 500 mg | 15580-500 | More Info |
| 2-bromo Deschloroketamine | An analytical reference standard categorized as an arylcyclohexylamine; in… | 1 mg | 30367-1 | More Info |
| 2-bromo Deschloroketamine | An analytical reference standard categorized as an arylcyclohexylamine; in… | 5 mg | 30367-5 | More Info |
| 2-bromo-4,5-Dimethoxyphenethylamine (hydrochloride) | An analytical reference standard categorized as phenethylamine; intended f… | 1 mg | 29386-1 | More Info |
| 2-bromo-4,5-Dimethoxyphenethylamine (hydrochloride) | An analytical reference standard categorized as phenethylamine; intended f… | 5 mg | 29386-5 | More Info |
| Bromodiphenhydramine (hydrochloride) | An H1 receptor antagonist; induces histamine release in isolated guinea pi… | 10 mg | 29636-10 | More Info |
| Bromodiphenhydramine (hydrochloride) | An H1 receptor antagonist; induces histamine release in isolated guinea pi… | 25 mg | 29636-25 | More Info |
| Bromodiphenhydramine (hydrochloride) | An H1 receptor antagonist; induces histamine release in isolated guinea pi… | 5 mg | 29636-5 | More Info |
| Bromodiphenhydramine (hydrochloride) | An H1 receptor antagonist; induces histamine release in isolated guinea pi… | 50 mg | 29636-50 | More Info |
| 4-bromo-2,5-DMA (hydrochloride) | A common hallucinogenic designer drug that avidly binds and activates sero… | 10 mg | 11142-10 | More Info |
| 4-bromo-2,5-DMA (hydrochloride) | A common hallucinogenic designer drug that avidly binds and activates sero… | 5 mg | 11142-5 | More Info |
| 4-bromo-2,5-DMA (hydrochloride) | A common hallucinogenic designer drug that avidly binds and activates sero… | 50 mg | 11142-50 | More Info |
| 4-bromo-2,5-DMA (hydrochloride) (exempt preparation) | A common hallucinogenic designer drug that avidly binds and activates sero… | 1 mg | 15683-1 | More Info |
| 4-bromo-2,5-DMMA | A designer drug patterned after 2,5-dimethylamphetamine compounds; intende… | 1 mg | 14788-1 | More Info |
| 4-bromo-2,5-DMMA | A designer drug patterned after 2,5-dimethylamphetamine compounds; intende… | 10 mg | 14788-10 | More Info |
| 4-bromo-2,5-DMMA | A designer drug patterned after 2,5-dimethylamphetamine compounds; intende… | 5 mg | 14788-5 | More Info |
| 12-Bromododecanoic Acid | A halogenated form of lauric acid; has been used in the synthesis of click… | 1 g | 30465-1 | More Info |
| 12-Bromododecanoic Acid | A halogenated form of lauric acid; has been used in the synthesis of click… | 250 mg | 30465-250 | More Info |
| 12-Bromododecanoic Acid | A halogenated form of lauric acid; has been used in the synthesis of click… | 500 mg | 30465-500 | More Info |
| Bromodomain Inhibitor Set | Consists of ~35 selective and non-selective bromodomain inhibitors and neg… | 1 ea | 28315-1EA | More Info |
| Bromo-DragonFLY (hydrochloride) | An analytical reference standard categorized as a phenethylamine; has been… | 1 mg | 11561-1 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile